Communicate with Supplier? Supplier
Jenny Dong Ms. Jenny Dong
What can I do for you?
+8618758474230
Chat Now
Contact Supplier
Yuyao Lifespan Health Technology Co., Ltd.

Yuyao Lifespan Health Technology Co., Ltd.

ydong@geneharbor.com.cn

86-0574-62101882

Yuyao Lifespan Health Technology Co., Ltd.
HomeNewsAugust 23, special notice | obtained FDA certification, Yuyao Lifespan`s 100-ton NMN capacity plant is now in production and our products were also certified by GMP fom FDA(US), the annual output of 100 tons of NMN pilot run of success

August 23, special notice | obtained FDA certification, Yuyao Lifespan`s 100-ton NMN capacity plant is now in production and our products were also certified by GMP fom FDA(US), the annual output of 100 tons of NMN pilot run of success

2020-08-23

nmn



In 2013, Harvard Medical School professor David Sinclair first showed that NMN could be taken orally to prevent aging in mammals.Since then, experimental studies on NMN have increased significantly.NMN can be seen in the Daily Mail of the UK, Wired, Science, Nature, Cell and other mainstream media in the US.In 2020 in Yuyao, Ningbo, NMN will achieve a successful pilot production of 100 tons per year.

In 2013, Harvard Medical School professor David Sinclair first showed that NMN could be taken orally to prevent aging in mammals.Since then, experimental studies on NMN have increased significantly.NMN can be seen in the Daily Mail of the UK, Wired, Science, Nature, Cell and other mainstream media in the US.In 2020 in Yuyao, Ningbo, NMN will achieve a successful pilot production of 100 tons per year.

At the meeting, Dr. Wang Jun, President of Geneport (Hong Kong) Biotechnology Co., Ltd., Chairman of Yuyao Raifosben Health Technology Co., Ltd., made an in-depth elaboration on the success of the pilot production of 100 tons of NMN per year and the far-reaching significance of passing FDA and GMP certification, and announced the new adjustment for the online sales reform of NMN.

Increasing the production line is of great significance for Raifoss, which means that NMN will be able to calmly face the huge market demand.The founder, Professor Wang Jun, has accumulated enzymatic technology for nearly 40 years and invested continuously in scientific research funds to achieve the success of mass production today.

It is reported that Gene Port launched NMN9000 series of products for the public in 2017, adopting all-natural and green production NMN patented technology, entering a new journey to explore health and longevity.

NMN has stable properties and rapid commercial transformation with the popularization of enzymatic process. At present, it has occupied the mainstream position of NAD+ anti-aging industry.

Although all kinds of NMN products are very popular in domestic and foreign e-commerce platforms and the market is very mature at present, they also face the problem of uneven quality. Many products without safety detection also appear on the market, and the industry begins to worry about their safety issues.Through the FDA certification, the safety of Raifoss has been strongly guaranteed.

Although all kinds of NMN products are very popular in domestic and foreign e-commerce platforms and the market is very mature at present, they also face the problem of uneven quality. Many products without safety detection also appear on the market, and the industry begins to worry about their safety issues.Through the FDA certification, the safety of Raifoss has been strongly guaranteed.


Yuyao Lifespan Health Technology Co., Ltd.
Business Type:Manufacturer
Product Range:Health Care Products
Products/Service:NMN Raw Materials , NMN Powder , Nicotinamide Mononucleotide , Coenzyme I , NMN Molecule , Nicotinamide Adenine Dinucleotide
Certificate:GMP , HACCP , ISO9001 , CSA , GS
Company Address:9 Xinghai Road, Binhai New Town, Yuyao Economic Development Zone, Ningbo, Zhejiang, China

Related Products List

Home

Product

Whatsapp

About Us

Inquiry